Description
The National Heart, Lung, and Blood Institute (NHLBI) sponsored the workshop to convene an interdisciplinary team of healthcare experts to discuss the current challenges that contribute to adverse outcomes when caring for older adults with heart failure (HF), including rehospitalizations (both HF-related and non-HF-related), functional decline, and diminished quality of life, with particular focus on care transitions. Participants comprised physicians, nurses, and pharmacists, including those with research and clinical expertise in cardiology, heart failure, geriatrics, palliative care, health disparities, clinical trials, biostatistics, epidemiology, mobile health technology, and health policy. The workshop was convened via videoconference on September 27-28, 2021 and consisted of two half-day sessions.
The workshop highlighted recent and ongoing clinical research involving a multitude of patient-focused, provider-focused, and system-focused challenges that could be addressed to improve clinical outcomes, including morbidity, quality of life, and mortality in patients with HF. The primary objective was to identify key knowledge gaps and future research opportunities that could be expected to have the greatest impact on quality of life and reducing hospitalizations in older adults with HF.
Recapitulation of major discussion topics
Introduction
Reducing the burden of heart failure (HF) is a priority of the NHLBI. In 2016, NHLBI unveiled its Strategic Vision after engaging nearly 4,500 diverse scientists and stakeholders from across the U.S. and 42 countries around the globe. The unprecedented number of ideas resulted in 4 research goals and 8 objectives, with each objective having critical research questions and challenges that collectively formed the Strategic Vision. Information on the NHLBI Strategic Vision is available at: https://www.nhlbi.nih.gov/about/strategic-vision. NHLBI Strategic Vision Objective 5 (Develop and optimize novel diagnostic and therapeutic strategies to prevent, treat, and cure heart, lung, blood, and sleep [HLBS] diseases) and Objective 6 (Optimize clinical and implementation research to improve health and reduce disease) were addressed by this workshop.
Discussions
After brief opening remarks and charge, the workshop focused on three specific areas to improve HF care transitions:
- Patient-level opportunities
- Provider-level opportunities
- Policy and system-level opportunities
The workshop began with a session that laid the groundwork for future discussions by reviewing the epidemiology and complexity of HF hospitalizations and care transitions from different healthcare professionals’ perspectives. This was followed by a session addressing some of the challenges that contribute to HF rehospitalizations and other adverse outcomes, including successes and failures of previous interventions and actions that may be required to improve outcomes in the future.
Factors contributing to HF rehospitalizations
Readmission within 30 days occurs in almost one in four patients after HF hospitalization and imposes tremendous burden to patients’ quality of life and national healthcare expenditures. Reasons for readmissions are numerous but include HF progression, iatrogenic causes, suboptimal adherence to effective medical therapies and self-care behaviors (symptom monitoring, diet and fluid restrictions, activity and exercise, follow-up appointments, etc.), complex comorbidities, insufficient social support, and provider-related factors such as non-prescription of guideline-directed medication and devices, healthcare delivery inequity, and inadequate follow-up. Older adults are at particular risk due to concomitant physical and/or cognitive decline, multiple comorbidities, frailty, fixed incomes and more complex medication regimens. Social determinants of health also play a central role in higher rehospitalization rates in this population.
Workshop participants discussed the importance of matching patient goals with outcomes. Current HF treatment paradigms do not adequately address frailty and function, which are essential considerations for the development and implementation of effective transitional care models in older, vulnerable patients. While several relatively small studies of transitional care interventions demonstrated efficacy, they have not yet been validated in large multi-center trials. Simple, scalable interventions implemented at early stages of HF, i.e., well before hospitalization occurs, may more effectively change the trajectory of the disease course with downstream benefits in reducing hospitalizations and functional decline while preserving independence and lowering healthcare costs.
Care Transitions
Workshop participants considered care transitions from a broad perspective, starting from the initial diagnosis of HF and continuing through the disease course, including hospitalizations and discharges, post-acute care, and transition to palliative care and hospice at end of life. Many opportunities exist to improve care transitions, including self-care education, lifestyle and behavioral changes, polypharmacy interventions, home care services, technology, post-acute rehabilitation, and palliative care. Participants noted that how and when to implement complex, multi-pronged interventions, e.g., before, during, or after hospitalization, are not well understood. Most discussants agreed that better metrics for evaluating care transitions are needed and that 30-day rehospitalization is a crude measure that fails to capture quality of care or longer-term patient-centered outcomes. Also, incentives are needed to encourage hospitals to extend care services beyond the hospitalization period. Novel algorithms of care developed using machine learning could potentially identify high-risk patients and match each patient with appropriate interventions to improve functional outcomes and even prevent a hospitalization. Components of transitional care that need refinement are optimal provider-patient/caregiver communication and collaboration that includes shared decision making, development of trusting relationships and delivery of optimal services via an individualized care plan.
Opportunities to Improve Care
Patient-Focused
- Discussion addressed a range of opportunities, including rehabilitation programs, self-care education, lifestyle factors, and use of telehealth and mobile technologies. Key themes that emerged were the importance of establishing trust between patient and provider and the need to integrate cultural and social factors into care at the individual patient level. Speakers identified specific ways that various interventions could be utilized to improve transitions and clinical outcomes. Some key gaps that remain are identifying which interventions for improving medication and dietary adherence and physical activity should be tested, how to improve health literacy in high-risk older patients, and how to incorporate social determinants of health into care pathways.
Provider-Focused
- Discussion addressed opportunities at the provider level, including reducing medication prescription complexity and polypharmacy and optimal utilization of post-acute care therapies, home care services, and palliative and hospice care. Discussants identified gaps in our understanding of how best to use services and how to align services with patients’ goals and preferences. There is a need for pragmatic trials that include patients of advanced age with multiple comorbidities and other vulnerabilities to study the effects of specialized services on rehospitalizations, physical function, and quality of life.
System-Focused
- Discussion in this session considered how national and payer policies affect HF care transitions. The Hospital Readmission Reduction Program (HRRP) has been modestly effective in reducing 30-day rehospitalizations at the possible expense of higher mortality. Thus, the best model for reducing HF rehospitalizations is not clear, and it is possible that different models are needed in different environments. Fee-for-service models do not offer necessary incentives for innovation or team-based care; potential policy solutions to payment challenges were considered. It was agreed that social determinants of health are major drivers of rehospitalization, and that addressing modifiable factors at the system level will be essential for optimizing care and outcomes.
Next Steps
The final session allowed all discussants and participants to share their opinions on which of the ideas discussed over the preceding sessions had the greatest potential to improve transitions, reduce hospitalizations, and optimize patient-centered outcomes in older patients with HF. Small breakout groups discussed specific approaches before sharing their consensus with the larger audience. There was general agreement that an overarching gap is the need for implementation science to determine how best to intervene in these patients to improve HF care. Key themes that were discussed included improving communication between providers and patients to better coordinate care transitions, embracing and addressing multi-morbidity and complexity in older HF patients, greater incorporation of patient-reported outcomes into care and payment models, and integrating social determinants of health into care pathways.
Selected References:
- Krumholz HM. Post-hospital syndrome--an acquired, transient condition of generalized risk. N Engl J Med. 2013 Jan 10;368(2):100-2. doi: 10.1056/NEJMp1212324. PMID: 23301730; PMCID: PMC3688067.
- Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, Paul S, Ryan CJ, White-Williams C; American Heart Association Complex Cardiovascular Patient and Family Care Committee of the Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015 Mar;8(2):384-409. doi: 10.1161/HHF.0000000000000006 PMID: 25604605
- Gorodeski EZ, Goyal P, Hummel SL, Krishnaswami A, Goodlin SJ, Hart LL, Forman DE, Wenger NK, Kirkpatrick JN, Alexander KP; Geriatric Cardiology Section Leadership Council, American College of Cardiology. Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future. J Am Coll Cardiol. 2018 May 1;71(17):1921-1936. PMID: 29699619; PMCID: PMC7304050; doi: 10.1016/j.jacc.2018.02.059
- Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management interventions for heart failure. Cochrane Database Syst Rev. 2019 Jan 8;1(1):CD002752. doi: 10.1002/14651858.CD002752.pub4. PMID: 30620776; PMCID: PMC6492456.
- White-Williams C, Rossi LP, Bittner VA, Driscoll A, Durant RW, Granger BB, Graven LJ, Kitko L, Newlin K, Shirey M; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention. Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2020 Jun 2;141(22):e841-e863. doi: 10.1161/CIR.0000000000000767. Epub 2020 Apr 30. PMID: 32349541.
Meeting Participants:
Workshop Chairs
- Nancy M. Albert, Ph.D., Associate Chief Nursing Officer, Office of Nursing Research and Innovation, Cleveland Clinic Health System
- Michael W. Rich, M.D., Professor of Medicine, Cardiovascular Division, John T. Milliken Department of Internal Medicine, Washington University School of Medicine in St. Louis
NHLBI Leads
- Jerome Fleg, MD, Medical Officer, Division of Cardiovascular Sciences (DCVS), NHLBI
- David Schopfer, MD, M.A.S., Medical Officer, DCVS, NHLBI
Speakers
- Larry Allen, M.D., Professor of Medicine, University of Colorado at Denver
- Cynthia Boyd, M.D., M.P.H., Professor of Medicine, Epidemiology, and Health Policy and Management, Johns Hopkins University
- Adam DeVore, M.D., M.H.S., Associate Professor of Medicine, Duke University
- Kumar Dharmarajan, M.D., M.B.A., Chief Scientific Officer and Associate Chief Medical Officer, Clover Health
- Gregg Fonarow, M.D., The Eliot Corday Professor of Cardiovascular Medicine and Science, David Geffen School of Medicine, UCLA
- Parag Goyal, M.D., M.Sc., Assistant Professor of Medicine, Weill Cornell Medicine
- Paul Heidenreich, M.D., M.S., Professor and Vice Chair for Quality, Department of Medicine, Stanford University; Chief of Medicine, VA Palo Alto Health Care System
- Adrian Hernandez, M.D., Vice Dean and Executive Director, Duke Clinical Research Institute, Duke University School of Medicine
- Corinne Jurgens, Ph.D., RN, Associate Professor, Connell School of Nursing, Boston College
- Jim Kirkpatrick, M.D., Professor of Medicine and Bioethics and Humanities, University of Washington
- Dalane Kitzman, M.D., Kermit G. Phillips Chair in Cardiovascular Medicine, Wake Forest School of Medicine
- Eldrin Lewis, M.D., M.P.H., Chief, Division of Cardiovascular Medicine, Stanford University
- Karen Joynt Maddox, MD, MPH, Associate Professor of Medicine, Cardiovascular Division, Washington University School of Medicine in St. Louis
- Nicole Orr, M.D., Assistant Professor of Medicine, Division of Cardiology, Tufts Medical Center
- Barbara Riegel, Ph.D., RN, Professor, School of Nursing, University of Pennsylvania
- Madeline Sterling, M.D., M.P.H., M.S., Assistant Professor of Medicine, Weill Cornell Medicine
- Lynne Stevenson, M.D., Professor of Medicine, Vanderbilt University Medical Center
- Harriette Van Spall, M.D., M.P.H., Associate Professor of Medicine, McMaster University
- Lucy West, PharmD, Heart Failure and Heart Transplant Clinical Pharmacist, Tufts Medical Center
- Clyde Yancy, M.D., M.Sc., Professor of Medicine and Medical Social Science; Vice Dean, Diversity and Inclusion, Northwestern University Feinberg School of Medicine
- Andrew Zullo, PharmD, Ph.D., Assistant Professor of Health Services, Policy, and Practice and Epidemiology, Brown University